Related Experiment Video

Updated: Jul 2, 2025

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.4K

Taming the beast: engineering strategies and biomedical potential of antibody-based cytokine mimetics

Lukas Pekar1, Simon Krah1, Stefan Zielonka1,2

  • 1Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.

Expert Opinion on Biological Therapy
|February 22, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AntibodyVHHantibody engineeringbispecific antibodycytokinecytokine mimeticsingle domain antibodysurrogate agonist

More Related Videos

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments12:28

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments

Published on: October 15, 2016

11.5K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K